This trial is testing whether the drug pregabalin can reduce the need for pain medication after ureteroscopy with stent placement, by giving it to patients before surgery. The trial is double-blinded, meaning neither the patients nor the staff will know who is receiving the drug or the placebo until after the study is completed.
- Kidney Stones
- Postoperative Pain
- Opioid Use Disorder
1 Primary · 6 Secondary · Reporting Duration: Within the first 30 days post-operation
Side Effects for
2 Treatment Groups
1 of 2
1 of 2
200 Total Participants · 2 Treatment Groups
Primary Treatment: Pregabalin 300mg · Has Placebo Group · Phase 2 & 3
Who is running the clinical trial?
Age 18+ · All Participants · 2 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many people have enrolled in this experiment?
"The information available on clinicaltrials.gov does suggest that this particular trial is recruiting patients at the moment. This trial was first posted on June 1st 2020 and received its latest update on October 20th 2021. The aim is to enroll 200 individuals from a single site." - Anonymous Online Contributor
What are the main indications for Pregabalin 300mg?
"Pregabalin 300mg is a medication typically used to treat fibromyalgia. However, it can also be an effective intervention for anxiety disorders, vitamin b12 deficiency, and issues with the spinal cord." - Anonymous Online Contributor
Are there still positions available for people who want to participate in this clinical trial?
"The clinical trial, which is currently looking for participants, was originally posted on 6/1/2020. The study has been updated as recently as 10/20/2021 according to the information available on clinicaltrials.gov" - Anonymous Online Contributor